These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35643491)

  • 41. "HIV is not an easily acceptable disease": the role of HIV-related stigma in obtaining cervical cancer screening in India.
    Gordon JR; Barve A; Chaudhari V; Kosambiya JK; Kumar A; Gamit S; Wells KJ
    Women Health; 2019 Aug; 59(7):801-814. PubMed ID: 30714510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Understanding facilitators and barriers to follow-up after abnormal cervical cancer screening examination among women living in remote areas of Romania: a qualitative study protocol.
    Nyanchoka L; Damian A; Nygård M
    BMJ Open; 2022 Feb; 12(2):e053954. PubMed ID: 35197342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Barriers and facilitators to cervical cancer screening uptake among women in Nepal - a qualitative study.
    Greibe Andersen J; Shrestha AD; Gyawali B; Neupane D; Kallestrup P
    Women Health; 2020 Oct; 60(9):963-974. PubMed ID: 32643576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "My husband says this: If you are alive, you can be someone…": Facilitators and barriers to cervical cancer screening among women living with HIV in India.
    Kung TH; Gordon JR; Abdullahi A; Barve A; Chaudhari V; Kosambiya JK; Kumar A; Gamit S; Wells KJ
    Cancer Causes Control; 2019 Apr; 30(4):365-374. PubMed ID: 30809741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
    Racey CS; Gesink DC
    J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient Factors Associated With Delays in Obtaining Cancer Care in Botswana.
    Bhatia RK; Rayne S; Rate W; Bakwenabatsile L; Monare B; Anakwenze C; Dhillon P; Narasimhamurthy M; Dryden-Peterson S; Grover S
    J Glob Oncol; 2018 Aug; 4():1-13. PubMed ID: 30199305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
    BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perceived benefits of cervical cancer screening among women attending Mahalapye District Hospital, Botswana.
    Ibekwe CM; Hoque ME; Ntuli-Ngcobo B
    Asian Pac J Cancer Prev; 2010; 11(4):1021-7. PubMed ID: 21133618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cervical cancer knowledge and barriers and facilitators to screening among women in two rural communities in Guatemala: a qualitative study.
    Bevilacqua KG; Gottschlich A; Murchland AR; Alvarez CS; Rivera-Andrade A; Meza R
    BMC Womens Health; 2022 May; 22(1):197. PubMed ID: 35643497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cervical Cancer Screening Knowledge and Behavior among Women Attending an Urban HIV Clinic in Western Kenya.
    Rosser JI; Njoroge B; Huchko MJ
    J Cancer Educ; 2015 Sep; 30(3):567-72. PubMed ID: 25595965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervical Cancer Screening in a Human Immunodeficiency Virus Treatment Centre in Zaria North-Western Nigeria.
    Yahya A; Mustapha A; Kolawole AOD; Oguntayo AO; Lawal BK
    West Afr J Med; 2022 Mar; 39(3):291-298. PubMed ID: 35380751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multilevel Factors Affecting Time to Cancer Diagnosis and Care Quality in Botswana.
    Brown CA; Kohler RE; John O; Motswetla G; Mmalane M; Tapela N; Grover S; Dryden-Peterson S; Lockman S; Dryden-Peterson SL
    Oncologist; 2018 Dec; 23(12):1453-1460. PubMed ID: 30082488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana.
    Grover S; Zetola N; Ramogola-Masire D; Bvochora-Nsingo M; Schnader AF; Mick R; Gabaitiri L; Matlhagela K; Shen H; Chiyapo S; Balang D; Phaladze N; Nkomazana O; Friedman H; Jemmott J; Chilisa B; Robertson ES
    BMJ Open; 2019 Dec; 9(12):e031103. PubMed ID: 31892649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of awareness on cervical cancer screening uptake among HIV positive women in Addis Ababa, Ethiopia: A cross-sectional study.
    Emru K; Abebaw TA; Abera A
    Womens Health (Lond); 2021; 17():17455065211017041. PubMed ID: 34096400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs.
    Grover S; Raesima M; Bvochora-Nsingo M; Chiyapo SP; Balang D; Tapela N; Balogun O; Kayembe MK; Russell AH; Monare B; Tanyala S; Bhat J; Thipe K; Nchunga M; Mayisela S; Kizito B; Ho-Foster A; Gaolebale BE; Gaolebale PA; Efstathiou JA; Dryden-Peterson S; Zetola N; Hahn SM; Robertson ES; Lin LL; Morroni C; Ramogola-Masire D
    Front Oncol; 2015; 5():239. PubMed ID: 26579491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vulvar cancer in Botswana in women with and without HIV infection: patterns of treatment and survival outcomes.
    MacDuffie E; Sakamuri S; Luckett R; Wang Q; Bvochara-Nsingo M; Monare B; Bazzett-Matabele L; Moloi T; Ralefala T; Ramogola-Masire D; Shin SS; Zetola NM; Grover S
    Int J Gynecol Cancer; 2021 Oct; 31(10):1328-1334. PubMed ID: 34493586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.
    Assefa AA; Astawesegn FH; Eshetu B
    BMC Health Serv Res; 2019 Nov; 19(1):847. PubMed ID: 31744548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human papillomavirus and cervical cancer risk perception and vaccine acceptability among adolescent girls and young women in Durban, South Africa.
    Russell VL; Ogilvie G; Beksinska M; Nyrenda M; Mitchell-Foster S; Lavoie J; Harder H; Wood B; Smith P; Dietrich JJ; Smit J; Brockman MA; Gray G; Kaida On Behalf Of The Ayazazi Research Team A
    S Afr Med J; 2020 Aug; 110(9):887-893. PubMed ID: 32880274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knowledge, perception of HIV symptom severity and cervical cancer screening behaviour among women living with HIV in China.
    Lin S; Chen WT; Gu C; Cheng HL; Wang H; Tang S
    Eur J Cancer Care (Engl); 2022 Mar; 31(2):e13542. PubMed ID: 34961999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cervical cancer screening among HIV-positive women in urban Uganda: a cross sectional study.
    Sarah Maria N; Olwit C; Kaggwa MM; Nabirye RC; Ngabirano TD
    BMC Womens Health; 2022 May; 22(1):148. PubMed ID: 35538482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.